Paul Alloway is of Homology Medicines, Inc.. Currently has a direct ownership of 2,596 shares of FIXX, which is worth approximately $0. The most recent transaction as insider was on Mar 25, 2024, when has been sold 268 shares (Common Stock) at a price of $24.21 per share, resulting in proceeds of $6,488. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.6K
0% 3M change
84.46% 12M change
Total Value Held $0

Paul Alloway Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 25 2024
SELL
Open market or private sale
$6,488 $24.21 p/Share
268 Reduced 9.36%
2,596 Common Stock
Mar 25 2024
BUY
Exercise of conversion of derivative security
-
23,530 Added 31.33%
51,566 Common Stock
Jan 03 2024
SELL
Open market or private sale
$4,149 $0.57 p/Share
7,280 Reduced 20.61%
28,036 Common Stock
Jan 01 2024
BUY
Exercise of conversion of derivative security
-
18,610 Added 34.51%
35,316 Common Stock
Mar 02 2023
SELL
Open market or private sale
$15,899 $1.45 p/Share
10,965 Reduced 39.63%
16,706 Common Stock
Jan 09 2023
SELL
Open market or private sale
$4,295 $1.39 p/Share
3,090 Reduced 13.32%
20,103 Common Stock
Jan 01 2023
BUY
Exercise of conversion of derivative security
-
9,570 Added 29.21%
23,193 Common Stock
PA

Paul Alloway

Bedford, MA

Track Institutional and Insider Activities on FIXX

Follow Homology Medicines, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FIXX shares.

Notify only if

Insider Trading

Get notified when an Homology Medicines, Inc. insider buys or sells FIXX shares.

Notify only if

News

Receive news related to Homology Medicines, Inc.

Track Activities on FIXX